Ansell Limited (ASX:ANN)
Australia · Delayed Price · Currency is AUD 42.31
+0.15 (0.36%)
Sep 18, 2026, 4:10 PM AEST
Ansell Market Cap
Ansell has a market cap or net worth of 5.87 billion as of September 18, 2026. Its market cap has increased by 21.34% in one year.
Market Cap
5.87B
Enterprise Value
6.65B
Revenue
3.09B
Ranking
n/a
PE Ratio
20.17
Stock Price
42.31
ChartMarket Cap Chart
Since January 16, 1992, Ansell's market cap has increased from 5.00B to 5.87B, an increase of 17.54%. That is a compound annual growth rate of 0.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 5.87B | 17.70% |
| Dec 31, 2025 | 4.99B | 1.96% |
| Dec 31, 2024 | 4.89B | 56.70% |
| Dec 29, 2023 | 3.12B | -12.08% |
| Dec 30, 2022 | 3.55B | -11.25% |
| Dec 31, 2021 | 4.00B | -10.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.09B |
| Sigma Healthcare | 29.33B |
| Pro Medicus | 17.71B |
| Ramsay Health Care | 12.75B |
| Sonic Healthcare | 9.51B |
| Cochlear | 8.76B |
| Telix Pharmaceuticals | 6.07B |
| Mesoblast | 2.74B |